Yahoo! Finance: Top Stories

Jim Cramer on Johnson & Johnson (JNJ): Tariff-Proof, Drug-Driven, and Still a Buy

Apr 20, 2025 - 02:05
 0
Jim Cramer on Johnson & Johnson (JNJ): Tariff-Proof, Drug-Driven, and Still a Buy
Read More

Tags:

Previous Article

Jim Cramer on Walmart Inc. (WMT): ‘Garden Variety Good’ Is More Than Enough

Next Article

Households in the West Have the Most Debt — Experts Explain Why

Related Posts